Kosaryan, Mehrnoush <br/><br/>
Report on patients with non transfusion-dependent β-thalassemia major being treated with hydroxyurea attending the Thalassemia Research Center, Sari, Mazandaran Province, Islamic Republic of Iran in 2013.  [electronic resource] 

 -  Hemoglobin  2014 
 - 115-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-432X 
<br/><br/><label>Standard No.: </label>10.3109/03630269.2013.869229  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antisickling Agents--therapeutic use<br/>Blood Cell Count<br/>Blood Transfusion<br/>Erythrocyte Indices<br/>Female<br/>Hematocrit<br/>Humans<br/>Hydroxyurea--therapeutic use<br/>Iran<br/>Male<br/>Mutation<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult<br/>beta-Globins--genetics<br/>beta-Thalassemia--drug therapy